Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: yosi s who wrote (1307)	9/29/1998 1:12:00 PM
From: Ariella	Read Replies (2) of 1491

Yosi -- I have to admit I cannot figure out what you are saying. The "delayed" news release to which you refer must be the one that will accompany the paper in Seattle on Oct. 7. I wouldn't call that delayed because it's not due till next week. However, today's release of information via Dow Jones is totally unexpected. The info about the meeting is given on the webpage for Pharmos and was covered in yesterday's WSJ article. Why repeat? The difference is that we're told about phase III trials taking place in the USA. If this is not a deliberate attempt to "leak" a good result for the unblinding, then it is an unconscious one. If the results were bad, and the stock tanked AFTER shareholders had just been told the drug would go on to last Phase of trials -- that would be rather odd, wouldn't it? My read is that good news is on the way next week..... Ariella

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next